Phosphorylation of the DNA helicase RECQ1 by MAPKAP kinase 2 promotes chemotherapeutic resistance in breast cancer.

被引：0
|
作者：
Maslar, K. [1 ]
Couillard, A. [1 ]
Strochlic, T. I. [1 ]
机构：
[1] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P3320
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response
    Salzano, Marcella
    Vazquez-Cedeira, Marta
    Sanz-Garcia, Marta
    Valbuena, Alberto
    Blanco, Sandra
    Fernandez, Isabel F.
    Lazo, Pedro A.
    ONCOTARGET, 2014, 5 (07) : 1770 - 1778
  • [32] Phosphorylation of Caspase-7 by p21-activated Protein Kinase (PAK) 2 Inhibits Chemotherapeutic Drug-induced Apoptosis of Breast Cancer Cell Lines
    Li, Xiang
    Wen, Weihong
    Liu, Kangdong
    Zhu, Feng
    Malakhova, Margarita
    Peng, Cong
    Li, Tingting
    Kim, Hong-Gyum
    Ma, Weiya
    Cho, Yong Yeon
    Bode, Ann M.
    Dong, Ziming
    Dong, Zigang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (25) : 22291 - 22299
  • [33] PIM1 kinase promotes cell migration via SHP2 in triple-negative breast cancer
    Maristany, F. Braso
    Quist, J.
    Wells, C.
    Grigoriadis, A.
    Marra, P.
    Tutt, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] The Kinase LMTK3 Promotes Invasion in Breast Cancer Through GRB2-Mediated Induction of Integrin β1
    Xu, Yichen
    Zhang, Hua
    Lit, Lei C.
    Grothey, Arnhild
    Athanasiadou, Maria
    Kiritsi, Marianna
    Lombardo, Ylenia
    Frampton, Adam E.
    Green, Andrew R.
    Ellis, Ian O.
    Ali, Simak
    Lenz, Heinz-Josef
    Thanou, Maya
    Stebbing, Justin
    Giamas, Georgios
    SCIENCE SIGNALING, 2014, 7 (330)
  • [35] Jun Amino-terminal Kinase 1 Activation Promotes Cell Survival in ErbB2-Positive Breast Cancer
    Han, Ji Seung
    Crowe, David L.
    ANTICANCER RESEARCH, 2010, 30 (09) : 3407 - 3412
  • [36] Differential roles of phosphoinositide-dependent protein kinase-1 and Akt1 expression and phosphorylation in breast cancer cell resistance to paclitaxel, doxorubicin, and gemcitabine
    Liang, Ke
    Lu, Yang
    Li, Xinqun
    Zeng, Xiao
    Glazer, Robert I.
    Mills, Gordon B.
    Fan, Zhen
    MOLECULAR PHARMACOLOGY, 2006, 70 (03) : 1045 - 1052
  • [37] Endoxifen Downregulates AKT Phosphorylation Through Protein Kinase C Beta 1 in ER+/HER2-Breast Cancer
    Jayaraman, Swaathi
    Wu, Xinyan
    Kalari, Krishna R.
    Tang, Xiaojia
    Kuffel, Mary
    Bruinsma, Elizabeth S.
    Renuse, Santosh
    Ingle, James N.
    Reid, Joel
    Schellenberg, Matthew
    Hawse, John
    Pandey, Akhilesh
    Goetz, Matthew P.
    CANCER RESEARCH, 2023, 83 (05)
  • [38] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance (vol 46, 138, 2021)
    Zong, Beige
    Sun, Lu
    Peng, Yang
    Wang, Yihua
    Yu, Yu
    Lei, Jinwei
    Zhang, Yingzi
    Guo, Shipeng
    Li, Kang
    Liu, Shengchun
    ONCOLOGY REPORTS, 2021, 46 (03)
  • [39] Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1
    Fang, Huan
    Ren, Wenlong
    Cui, Qiuxia
    Liang, Huichun
    Yang, Chuanyu
    Liu, Wenjing
    Wang, Xinye
    Liu, Xue
    Shi, Yujie
    Feng, Jing
    Chen, Ceshi
    ELIFE, 2023, 12
  • [40] Jab1/Csn5 a new player driving the resistance to Her2-targeted therapies for breast cancer.
    Vu, Thuy T.
    Shackleford, Terry J.
    Zhang, Qingxiu
    Esteva, Francisco J.
    Drakos, Elias
    Tian, Ling
    Kute, Timothy
    Sahin, Aysegul A.
    Rassidakis, George Z.
    Claret, Francois X.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345